ANTIGEN BINDING PROTEINS
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to antigen binding proteins comprising two Fc parts, methods for their production, pharmaceutical compositions containing said antigen binding proteins, and uses thereof.
5 Citations
33 Claims
-
1-17. -17. (canceled)
-
18. A method for the preparation of an antigen binding protein comprising the steps of
a) transforming a host cell with vectors comprising nucleic acid molecules encoding the antigen binding protein, b) culturing the host cell under conditions that allow synthesis of said antigen binding protein molecule; - and
c) recovering said antigen binding protein molecule from said culture;
whereinthe antigen binding protein comprises i) two modified heavy chains of an antibody which specifically binds to an antigen, wherein VH of each heavy chain is replaced by the VL of said antibody, said modified heavy chains being associated with each other via their CH3 domains of the Fc part; ii) two modified heavy chains of said antibody wherein CH1 of each heavy chain is replaced by CL of said antibody, said modified heavy chains being associated with each other via their CH3 domains of the Fc part; and wherein the VL domains of the heavy chains of i) are associated with the VH domains of the heavy chains of ii), and the CH1 domains of the heavy chains of i) are associated with the CL domains of the heavy chains of ii). - View Dependent Claims (22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)
- and
-
19. A nucleic acid encoding an antigen binding protein, wherein
the antigen binding protein comprises i) two modified heavy chains of an antibody which specifically binds to an antigen, wherein VH of each heavy chain is replaced by the VL of said antibody, said modified heavy chains being associated with each other via their CH3 domains of the Fc part; -
ii) two modified heavy chains of said antibody wherein CH1 of each heavy chain is replaced by CL of said antibody, said modified heavy chains being associated with each other via their CH3 domains of the Fc part; and wherein the VL domains of the heavy chains of i) are associated with the VH domains of the heavy chains of ii), and the CH1 domains of the heavy chains of i) are associated with the CL domains of the heavy chains of ii). - View Dependent Claims (20, 21)
-
Specification